BioInsights - Home page

IMMUNO-ONCOLOGY INSIGHTS

August 2023 Issue

Vol 4 Issue 7

<em> In vivo</em> tools for preclinical applications

Tools and Technologies focus:

In vivo tools for preclinical applications
View
Immuno-oncology Vol 4 Issue 7
View

Upcoming webinars

Advancing clinical-grade tumor-infiltrating lymphocyte therapy manufacturing

Advancing clinical-grade tumor-infiltrating lymphocyte therapy manufacturing

Arina Riabinska
24 October
in 29
Days
Register
View all webinars

Latest Articles

Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Christoph Eberle
21 September
Innovator Insight
iNKT cells for allogeneic cell therapy

iNKT cells for allogeneic cell therapy

Eleni Chantzoura, Paul Ibbett
30 August
Viewpoint
Reducing risk for cell therapy manufacturing with a battle-tested electroporation platform

Reducing risk for cell therapy manufacturing with a battle-tested electroporation platform

Andrew Mancini
24 August
FastFacts
Developing universal AAV immuno-gene therapy for oncology

Developing universal AAV immuno-gene therapy for oncology

Nicole Paulk
23 August
Interview
Modulating the tumor microenvironment through chemokine disruption

Modulating the tumor microenvironment through chemokine disruption

Avital Barak
23 August
Interview
Does synthetic biology hold the key to unlocking solid tumors for cell and gene therapy?

Does synthetic biology hold the key to unlocking solid tumors for cell and gene therapy?

Ming-Ru Wu
20 August
Interview
Rearming the immune system with personalized allogeneic CAR-T cell therapy

Rearming the immune system with personalized allogeneic CAR-T cell therapy

Olivier Negre
17 August
Interview
European research infrastructures join forces to provide innovative cancer research services across Europe—how can they support the cell and gene therapy developer?

European research infrastructures join forces to provide innovative cancer research services across Europe—how can they support the cell and gene therapy developer?

E Oldoni, P Carvajal-Vallejos, F Bietrix et al.
10 August
Editorial
Applying multiomics to novel target discovery in immuno-oncology

Applying multiomics to novel target discovery in immuno-oncology

Eran Ophir, Yaron Turpaz
8 August
Interview

Channel content